Helpful explanatory models for somatoform symptoms (HERMES): study protocol of a randomised mixed-methods pilot trial

被引:3
|
作者
Huesing, Paul [1 ]
Loewe, Bernd [1 ]
Hartman, Tim C. Olde [2 ]
Frostholm, Lisbeth [3 ]
Weigel, Angelika [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany
[2] Radboud Univ Nijmegen, Dept Primary & Community Care, Med Ctr, Nijmegen, Netherlands
[3] Aarhus Univ Hosp, Res Clin Funct Disorders & Psychosomat, Aarhus, Denmark
来源
BMJ OPEN | 2021年 / 11卷 / 03期
关键词
psychiatry; general medicine (see internal medicine); primary care; preventive medicine; MEDICALLY UNEXPLAINED SYMPTOMS; PERSISTENT SOMATIC SYMPTOMS; BODILY DISTRESS DISORDER; CRITERIA SCALE SSD-12; PRIMARY-CARE; PATIENTS PERCEPTIONS; PHYSICAL SYMPTOMS; VALIDITY; SOMATIZATION; POPULATION;
D O I
10.1136/bmjopen-2020-044244
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Persistent somatic symptoms (PSS) are common both in the general population and primary care. They are bothersome in terms of psychological and somatic symptom burden. Health professionals often struggle with communication, as there is a lack of scientifically supported explanatory models for PSS or a focus merely on somatic aspects of the complaints, which both frustrate patients' needs. The objective of the present study is therefore to develop a psychoeducational intervention based on a current evidence-based explanatory model, to examine its feasibility and form the basis for a large-scale randomised controlled trial. Methods and analysis In a randomised controlled mixed-methods pilot trial, 75 adult psychosomatic outpatients with PSS (duration of symptoms >= 6 months) and accompanying psychological (Somatic Symptom B-Criteria Scale total score >= 18) and somatic symptom burden (Patient Health Questionnaire-15 score >10) and no prior psychosomatic treatment will be eligible. Participants will be presented with either the explanatory model without (intervention group 1, n=25) or with elements of personalisation (intervention group 2, n=25). Participants in the control group (n=25) will receive information on current PSS guidelines. Participants will be blinded to group assignment and interventions will be shown on tablet computers at the outpatient clinic. After 1 month, qualitative follow-up telephone interviews will be conducted. As primary outcomes, mean changes in psychological and somatic symptom burden will quantitatively be compared between groups, respectively. Behavioural change mechanisms and feasibility of the three interventions will be evaluated using quantitative and qualitative measures. Ethics and dissemination Ethics approval has been granted by the medical ethics board of the Hamburg Medical Chamber (PV5653). Results from this study will be published in peer-reviewed journals and presented at national and international conferences.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Impact of a multimedia website with patient experiences of multiple sclerosis (PExMS) on immunotherapy decision-making: study protocol for a pilot randomised controlled trial in a mixed-methods design
    Anna Barabasch
    Karin Riemann-Lorenz
    Christopher Kofahl
    Jutta Scheiderbauer
    Desiree Eklund
    Ingo Kleiter
    Jürgen Kasper
    Sascha Köpke
    Susanne Lezius
    Antonia Zapf
    Anne Christin Rahn
    Christoph Heesen
    Pilot and Feasibility Studies, 7
  • [22] Impact of a multimedia website with patient experiences of multiple sclerosis (PExMS) on immunotherapy decision-making: study protocol for a pilot randomised controlled trial in a mixed-methods design
    Barabasch, Anna
    Riemann-Lorenz, Karin
    Kofahl, Christopher
    Scheiderbauer, Jutta
    Eklund, Desiree
    Kleiter, Ingo
    Kasper, Jurgen
    Kopke, Sascha
    Lezius, Susanne
    Zapf, Antonia
    Rahn, Anne Christin
    Heesen, Christoph
    PILOT AND FEASIBILITY STUDIES, 2021, 7 (01)
  • [23] A prospective randomised controlled mixed-methods pilot study of home monitoring in adults with cystic fibrosis
    Nash, Edward F.
    Choyce, Jocelyn
    Carrolan, Victoria
    Justice, Edwin
    Shaw, Karen L.
    Sitch, Alice
    Mistry, Hema
    Whitehouse, Joanna L.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [24] A prospective randomised controlled mixed-methods pilot study of home monitoring in adults with cystic fibrosis
    Nash, Edward F.
    Choyce, Jocelyn
    Carrolan, Victoria
    Justice, Edwin
    Shaw, Karen L.
    Sitch, Alice
    Mistry, Hema
    Whitehouse, Joanna L.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [25] Peer support impact on therapeutic adherence in patients with multiple sclerosis: a mixed-methods pilot trial protocol
    Guilmault, Leonor
    Wiertlewski, Sandrine
    Malloggi, Lucie
    Rousseau, Cecilia
    Jacq-Foucher, Marylene
    Leclere, Brice
    Moret, Leila
    BMJ OPEN, 2023, 13 (12):
  • [26] Reducing Speaking Anxiety in EFL Classrooms: An Explanatory Mixed-Methods Study
    Olmezer-Ozturk, Elcin
    Ozturk, Gokhan
    PORTA LINGUARUM, 2021, (36) : 249 - 261
  • [27] American Muslims and Vicarious Trauma: An Explanatory Concurrent Mixed-Methods Study
    Ashraf, Anjabeen
    Nassar, Sylvia
    AMERICAN JOURNAL OF ORTHOPSYCHIATRY, 2018, 88 (05) : 516 - 528
  • [28] Stroke Survivors' and Informal Caregivers' Perceptions of Depressive Symptoms After Stroke: An Explanatory Sequential Mixed-Methods Study
    Trotter, Tanya
    Denny, Dawn
    Evanson, Tracy
    Ferraro, Ric
    O'Malley, Patricia
    WESTERN JOURNAL OF NURSING RESEARCH, 2024, 46 (01) : 36S - 36S
  • [29] Neuropsychological evaluation and rehabilitation in multiple sclerosis (NEuRoMS): protocol for a mixed-methods, multicentre feasibility randomised controlled trial
    Topcu, Gogem
    Smith, Laura
    Mhizha-Murira, Jacqueline R.
    Goulden, Nia
    Hoare, Zoe
    Drummond, Avril
    Fitzsimmons, Deborah
    Evangelou, Nikos
    Schmierer, Klaus
    Tallantyre, Emma C.
    Leighton, Paul
    Allen-Philbey, Kimberley
    Stennett, Andrea
    Bradley, Paul
    Bale, Clare
    Turton, James
    das Nair, Roshan
    PILOT AND FEASIBILITY STUDIES, 2022, 8 (01)
  • [30] Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery
    Shickh, Salma
    Hirjikaka, Daena
    Clausen, Marc
    Kodida, Rita
    Mighton, Chloe
    Reble, Emma
    Sam, Jordan
    Panchal, Seema
    Aronson, Melyssa
    Graham, Tracy
    Armel, Susan Randall
    Glogowski, Emily
    Elser, Christine
    Eisen, Andrea
    Carroll, June C.
    Shuman, Cheryl
    Seto, Emily
    Baxter, Nancy N.
    Scheer, Adena
    Shastri-Estrada, Serena
    Feldman, Geoff
    Thorpe, Kevin E.
    Schrader, Kasmintan A.
    Lerner-Ellis, Jordan
    Kim, Raymond H.
    Faghfoury, Hanna
    Bombard, Yvonne
    BMJ OPEN, 2022, 12 (04):